![](/img/cover-not-exists.png)
4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a
P. de Souza, K. Maart, A. Laurell, R.E. Hawkins, A. Berkenblit, L. Galand, A. Thiele, A. Strahs, J. Feingold, G. HudesVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)71079-0
File:
PDF, 85 KB
english, 2007